OxySure Systems (OXYS) Announces Investor Day at its Headquarters in Frisco, Texas

Report this content

Frisco, Texas, August 4, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (OxySure, or the Company), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology, today announced the Company will conduct an Investor Day, from 10:00 a.m. to 12:30 p.m. (CST) on Tuesday, September 15, 2015. The event will be at the Company’s headquarters, located at 10880 John W. Elliott Drive, Suite 600, Frisco, Texas 75033.

Availability for interested parties is extremely limited. Those interested in attending should contact Kathryn Jayne at 972-294-6551 or at kjayne@oxysure.com. For those unable to attend, the presentations are to be webcast and available through a link on the investor relations' portion of OxySure's website.

A tour of the Company’s production plant and operations will be provided. Mr. Julian Ross, OxySure's Chief Executive Officer and President, is to lead a discussion and update on the Company’s progress and operations, and will be available for a question and answer session. In addition, the Company’s Board of Directors and Advisory Board members will be present and available for discussion and questions. Cliff Meidl, Two-Time Olympian, USA Olympic Team Flag Bearer and OxySure Spokesman will provide a motivational presentation, as well as other survivors who will be available to share their lifesaving and life changing stories.

About OxySure Systems, Inc.

OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from two dry, inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.

OxySure Contacts:

Renmark Financial Communications, Inc.

Bettina Filippone: bfilippone@renmarkfinancial.com

Tel.: (416) 644-2020 or (514) 939-3989

www.renmarkfinancial.com/

Redchip Companies, Inc.

Jon Cunningham: jon@redchip.com

800-733-2447, ext. 107 | www.redchip.com/

Tags:

Documents & Links